Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan List

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Blood|August 11, 2011
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3AAnna M Jankowska, Hideki Makishima, Ramon V Tiu, et al.
Cancer Medicine|April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomideDana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Leukemia|July 21, 2018
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMMLSandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, et al.
The Lancet. Oncology|February 24, 2009
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyPierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeMohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
The Journal of Clinical Investigation|November 13, 2013
Induction of myelodysplasia by myeloid-derived suppressor cellsXianghong Chen, Erika A Eksioglu, Junmin Zhou, et al.
The New England Journal of Medicine|September 10, 2010
Persistent malignant stem cells in del(5q) myelodysplasia in remissionRamin Tehranchi, Petter S Woll, Kristina Anderson, et al.
Blood|February 8, 2013
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signalingTushar D Bhagat, Li Zhou, Lubomir Sokol, et al.
Blood|August 4, 2012
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
Blood|May 4, 2012
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesisAndres Jerez, Yuka Sugimoto, Hideki Makishima, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Blood|August 11, 2011
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3AAnna M Jankowska, Hideki Makishima, Ramon V Tiu, et al.
Cancer Medicine|April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomideDana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Leukemia|July 21, 2018
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMMLSandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, et al.
The Lancet. Oncology|February 24, 2009
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studyPierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeMohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
The Journal of Clinical Investigation|November 13, 2013
Induction of myelodysplasia by myeloid-derived suppressor cellsXianghong Chen, Erika A Eksioglu, Junmin Zhou, et al.
The New England Journal of Medicine|September 10, 2010
Persistent malignant stem cells in del(5q) myelodysplasia in remissionRamin Tehranchi, Petter S Woll, Kristina Anderson, et al.
Blood|February 8, 2013
miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signalingTushar D Bhagat, Li Zhou, Lubomir Sokol, et al.
Blood|August 4, 2012
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaAndres Jerez, Michael J Clemente, Hideki Makishima, et al.
Blood|May 4, 2012
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesisAndres Jerez, Yuka Sugimoto, Hideki Makishima, et al.
Pageof 8